Most Recent

image: Amoeba Eats Cells Alive

Amoeba Eats Cells Alive

By | April 9, 2014

The intestinal parasite Entamoeba histolytica kills host cells by tearing pieces from them, which it then eats.

2 Comments

image: Bridging Two Worlds

Bridging Two Worlds

By | April 4, 2014

Lynne Quarmby’s love of the natural world inspires her to explore beyond her cell biology lab through art.

0 Comments

image: Week in Review: March 31–April 4

Week in Review: March 31–April 4

By | April 4, 2014

Transcriptional landscape of the fetal brain; how a parasitic worm invades plants; difficulties reproducing “breakthrough” heart regeneration method; oxytocin and dishonesty

1 Comment

image: Stripes Shoo Flies

Stripes Shoo Flies

By | April 4, 2014

Zebras evolved stripes to prevent pesky biting flies from landing on them, a study finds.

1 Comment

image: Misconduct Found in STAP Case

Misconduct Found in STAP Case

By | April 2, 2014

An investigating committee at Japan’s RIKEN research center finds evidence of falsification and fabrication in two recent Nature papers that touted a new way to induce pluripotency.

1 Comment

image: Elusive Receptor ID’d

Elusive Receptor ID’d

By | April 1, 2014

Scientists identify an extracellular ATP receptor in plants.

0 Comments

image: Going Long

Going Long

By | April 1, 2014

Researchers discover a tool to trigger an uncommon strategy cancer cells can use to lengthen their telomeres.

0 Comments

image: Maria Spies: Molecular Machinist

Maria Spies: Molecular Machinist

By | April 1, 2014

Associate Professor, Biochemistry, University of Iowa, Age: 40

0 Comments

image: Molecular Multitasker

Molecular Multitasker

By | April 1, 2014

Scientists create a way to isolate mRNA from a single living cell within a tissue.

0 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2014

April 2014's selection of notable quotes

2 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham